SS Innovations International, Inc.

SSII Nasdaq SEC CIK 1676163
Follow SS Innovations International Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $6.3M −50.7% vs same quarter last year
Net income −$5.7M −54.6% vs same quarter last year
EPS, diluted −$0.03 −50% vs same quarter last year
Operating cash flow −$6.4M +14.7% vs same quarter last year
Revenue by quarter
$8.1M
$5.1M
$10M
$12.8M
$14.5M
$11.1M
$13.9M
$6.3M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income11 fiscal years
  • Revenue
  • Net income
−$40M−$20M$0$20M$40M$60MFY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$42.5M−$12.1M
FY24$20.6M−$19.2M
FY23$5.9M−$20.9M
FY22$1.4M−$3.2M
FY21-−$1.5M
FY20-−$1.1M
FY19-−$3.4M
FY18-−$960.3K
FY17-−$1M
FY16-−$485K
FY15--
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−400%−200%0%200%FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2546%−19.3%−28.5%
FY2440.9%−91.9%−92.7%
FY2312.3%−345.1%−355.4%
FY224.2%−206%−223.8%
FY21---
FY20---
FY19---
FY18---
FY17---
FY16---
FY15---
Free cash flowOperating cash flow minus capital expenditure
−$30M−$20M−$10M$0FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25−$22.2M
FY24−$10.2M
FY23−$15.8M
FY22−$6.2M
FY21-
FY20-
FY19-
FY18-
FY17-
FY16-
FY15-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • SS Innovations International
  • Healthcare median
−400%−300%−200%−100%0%FY15FY17FY19FY21FY23FY25
Show the numbers
YearSS Innovations InternationalHealthcare median
FY25−28.5%−30.6%
FY24−92.7%−47%
FY23−355.4%−58%
FY22−223.8%−80.4%
FY21-−71.9%
FY20-−62.2%
FY19-−46.3%
FY18-−49.6%
FY17-−45.9%
FY16-−36%
FY15-−38.4%